The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa

BACKGROUND: MammaPrint (MP) has been applied in South Africa (SA) for decision-making in early-stage hormone receptor-positive breast cancer since 2006. The cost-impact of MP in SA has not been assessed. AIM: To assess different MP testing strategies for cost-minimization in early-stage breast carci...

Descripción completa

Detalles Bibliográficos
Autores principales: Myburgh, Ettienne J., de Jager, Josephus J., Murray, Elizabeth, Grant, Kathleen A., Kotze, Maritha J., de Klerk, Hermanus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259301/
https://www.ncbi.nlm.nih.gov/pubmed/34217105
http://dx.doi.org/10.1016/j.breast.2021.05.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259301/
https://www.ncbi.nlm.nih.gov/pubmed/34217105
http://dx.doi.org/10.1016/j.breast.2021.05.010

Ejemplares similares